FI970703A0 - Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine - Google Patents

Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine

Info

Publication number: FI970703A0
Authority: FI; Finland
Prior art keywords: pct; hydrolyzed collagen; containing substance; neutral taste; osteoporosis
Prior art date: 1994-08-23

Application number

FI970703A

Other languages

English (en)

Swedish (sv)

Other versions

FI118513B (fi

FI970703L (fi

Inventor

Adam Milan

Bernd Eggersgluess

Klaus Braeumer

Reinhard Schrieber

Original Assignee

Dgf Stoess Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-23

Filing date

1997-02-19

Publication date

1997-02-19

1997-02-19 Application filed by Dgf Stoess Ag filed Critical Dgf Stoess Ag

1997-02-19 Publication of FI970703A0 publication Critical patent/FI970703A0/fi

1997-02-19 Publication of FI970703L publication Critical patent/FI970703L/fi

2007-12-14 Application granted granted Critical

2007-12-14 Publication of FI118513B publication Critical patent/FI118513B/fi

Links

102000008186 Collagen Human genes 0.000 title abstract 2
108010035532 Collagen Proteins 0.000 title abstract 2
229920001436 collagen Polymers 0.000 title abstract 2
230000007935 neutral effect Effects 0.000 title 1
239000000126 substance Substances 0.000 title 1
108010010803 Gelatin Proteins 0.000 abstract 2
208000001132 Osteoporosis Diseases 0.000 abstract 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
229920000159 gelatin Polymers 0.000 abstract 2
239000008273 gelatin Substances 0.000 abstract 2
235000019322 gelatine Nutrition 0.000 abstract 2
235000011852 gelatine desserts Nutrition 0.000 abstract 2
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
210000002808 connective tissue Anatomy 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Seasonings (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cosmetics (AREA)

FI970703A 1994-08-23 1997-02-19 Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine FI118513B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE4429842		1994-08-23
DE4429842		1994-08-23
EP9503304		1995-08-19
PCT/EP1995/003304 WO1996005851A1 (de)	1994-08-23	1995-08-19	Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe

Publications (3)

Publication Number	Publication Date
FI970703A0 true FI970703A0 (fi)	1997-02-19
FI970703L FI970703L (fi)	1997-02-19
FI118513B FI118513B (fi)	2007-12-14

Family

ID=6526329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI970703A FI118513B (fi)	1994-08-23	1997-02-19	Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine

Country Status (12)

Country	Link
US (1)	US5948766A (fi)
EP (1)	EP0777491B1 (fi)
JP (1)	JPH10504555A (fi)
AT (1)	ATE282423T1 (fi)
AU (1)	AU703137B2 (fi)
CA (1)	CA2198099C (fi)
DE (1)	DE59510968D1 (fi)
ES (1)	ES2233947T3 (fi)
FI (1)	FI118513B (fi)
NO (1)	NO318182B1 (fi)
PT (1)	PT777491E (fi)
WO (1)	WO1996005851A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4609807B2 (ja) *	1996-03-28	2011-01-12	雪印乳業株式会社	骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) *	1997-06-18	1999-01-19	Zenyaku Kogyo Kk	骨粗鬆症予防・治療剤
US7691829B2 (en) *	1998-03-24	2010-04-06	Petito George D	Composition and method for healing tissues
US20050208114A1 (en) *	1998-03-24	2005-09-22	Petito George D	Composition and method for healing tissues
JP2009148275A (ja) *	2000-08-30	2009-07-09	Morisuke Yokoyama	特定保健用食品
ITRM20010380A1 (it) *	2001-07-02	2003-01-02	Bioprogress Spa	Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
JP4766818B2 (ja) *	2002-07-24	2011-09-07	隆文小濱	妊娠時に特異的な腰痛、股関節痛及び鼠径部痛の改善・治療剤
DE10339180A1 (de) *	2003-08-21	2005-03-24	Deutsche Gelatine-Fabriken Stoess Ag	Kollagenhydrolysat
CN101166429A (zh) *	2005-04-13	2008-04-23	雪印乳业株式会社	营养组合物
CA2623940C (en)	2005-09-27	2017-01-10	Tissuetech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
US8187639B2 (en)	2005-09-27	2012-05-29	Tissue Tech, Inc.	Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
ES2288791B1 (es) *	2006-02-10	2008-12-01	Masterfarm, S.L.	Procedimiento de obtencion de un hidrolizado de colageno. hidrolizado enzimatico de colageno obtenible por el procedimiento y usos del mismo.
ES2298071B1 (es) *	2006-10-25	2009-07-28	Masterfarm,S.L.	Hidrolizado enzimatico de colageno y procedimiento de obtencion.
EP2120989A1 (en) *	2007-03-21	2009-11-25	DSM IP Assets B.V.	Cholesterol lowering protein hydrolysates
JP2008231065A (ja) *	2007-03-23	2008-10-02	Chisso Corp	骨代謝改善剤
US9375437B2 (en)	2010-06-18	2016-06-28	Lipocine Inc.	Progesterone containing oral dosage forms and kits
US20110312928A1 (en) *	2010-06-18	2011-12-22	Lipocine Inc.	Progesterone Containing Oral Dosage Forms and Related Methods
DE102011000997A1 (de)	2011-03-01	2012-09-06	Gelita Ag	Zusammensetzung für Ernährungszwecke
US9526770B2 (en) *	2011-04-28	2016-12-27	Tissuetech, Inc.	Methods of modulating bone remodeling
US8951996B2 (en)	2011-07-28	2015-02-10	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
DE102012110612A1 (de)	2012-11-06	2014-05-08	Gelita Ag	Kollagenhydrolysat und dessen Verwendung
PL2948003T3 (pl)	2013-01-23	2021-01-25	Bottled Science Limited	Kompozycja napoju poprawiająca skórę
BR112017027688A2 (pt)	2015-06-22	2018-09-04	Lipocine Inc	Composições orais que contêm éster de 17- hidroxiprogesterona e métodos relacionados
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
EP3595695A1 (en) *	2017-03-15	2020-01-22	Rousselot B.V.	Compositions of hydrolyzed collagen peptides and commensal microorganisms and methods thereof
DE102019202606A1 (de)	2018-11-06	2020-05-07	Gelita Ag	Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102020126594A1 (de) *	2020-10-09	2022-04-14	Gelita Ag	Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
DE102021119031B4 (de)	2021-07-22	2024-08-08	Manfred Lotz	Behandlung von Polymyalgia Rheumatica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1227534A (fi) *	1967-08-31	1971-04-07
CA1302880C (en) *	1986-07-25	1992-06-09	Peter Koepff	Agents for the treatment of arthroses
DE3626414C2 (de) *	1986-08-05	1994-11-10	Robapharm Ag	Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
CN1045719C (zh) *	1993-04-10	1999-10-20	北京市西城区华新生化技术研究所	口服接骨和治骨质疏松液
US5641747A (en) *	1994-07-25	1997-06-24	Temple University-Of The Commonwealth System Of Higher Education	Treatment of osteopetrotic diseases

1995
- 1995-08-19 ES ES95929893T patent/ES2233947T3/es not_active Expired - Lifetime
- 1995-08-19 JP JP8507790A patent/JPH10504555A/ja active Pending
- 1995-08-19 CA CA002198099A patent/CA2198099C/en not_active Expired - Fee Related
- 1995-08-19 EP EP95929893A patent/EP0777491B1/de not_active Expired - Lifetime
- 1995-08-19 WO PCT/EP1995/003304 patent/WO1996005851A1/de not_active Ceased
- 1995-08-19 AU AU33470/95A patent/AU703137B2/en not_active Ceased
- 1995-08-19 PT PT95929893T patent/PT777491E/pt unknown
- 1995-08-19 US US08/793,252 patent/US5948766A/en not_active Expired - Lifetime
- 1995-08-19 AT AT95929893T patent/ATE282423T1/de active
- 1995-08-19 DE DE59510968T patent/DE59510968D1/de not_active Expired - Lifetime
1997
- 1997-02-19 FI FI970703A patent/FI118513B/fi active IP Right Grant
- 1997-02-21 NO NO19970805A patent/NO318182B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0777491A1 (de)	1997-06-11
AU703137B2 (en)	1999-03-18
AU3347095A (en)	1996-03-14
NO970805D0 (no)	1997-02-21
NO970805L (no)	1997-02-21
CA2198099C (en)	2001-01-16
DE59510968D1 (de)	2004-12-23
FI118513B (fi)	2007-12-14
ES2233947T3 (es)	2005-06-16
ATE282423T1 (de)	2004-12-15
WO1996005851A1 (de)	1996-02-29
EP0777491B1 (de)	2004-11-17
US5948766A (en)	1999-09-07
CA2198099A1 (en)	1996-02-29
NO318182B1 (no)	2005-02-14
FI970703L (fi)	1997-02-19
JPH10504555A (ja)	1998-05-06
PT777491E (pt)	2005-01-31

Publication	Publication Date	Title
FI970703A0 (fi)	1997-02-19	Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine
PT831882E (pt)	2005-01-31	Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas
ATE239037T1 (de)	2003-05-15	Zusammensetzung zur behandlung von nierenversagen
FI971967A0 (fi)	1997-05-07	Dioksomorfoliinien käyttö sisäloisten torjuntaan, uusia dioksomorfiineja ja menetelmä niiden valmistamiseksi
DE69507029D1 (de)	1999-02-11	Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
NO2014010I1 (no)	2014-06-02	Radium 223 salt slik som Radium 223 diklorid
FI970101A0 (fi)	1997-01-10	Uusi farmaseuttinen valmiste kivun hallintaan
ATE235253T1 (de)	2003-04-15	Prophylaktische immunisierende milchpräparation gegen otitis
ES516561A0 (es)	1983-12-01	Procedimiento para la obtencion de acidos 1-carboxi-(alcanoil o aralcanoil)-indolin-2-carboxilicos.
KR927003079A (ko)	1992-12-17	골격 치유방법 및 치료용 조성물
DK0774962T3 (da)	2004-08-09	Anvendelse af DHA i behandlingen af ordblindhed
DE69526937D1 (de)	2002-07-11	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
FI971951A0 (fi)	1997-05-07	2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
DE69516503D1 (de)	2000-05-31	Piperidinderivate mit paf antagonistischer wirkung
DK92689A (da)	1990-08-28	Oralt indgiveligt calciumtilskud til kvaeg
HUT77289A (hu)	1998-03-30	Az N-terminálison szulfonil- vagy szulfamoil-csoportokat tartalmazó dipeptid-(p-amido-benzil)-amidok
BR9509975A (pt)	1998-06-09	Formulação farmacêutica
NO971182L (no)	1997-05-14	Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
TR199701121T1 (xx)	1998-03-21	Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
DE69634487D1 (de)	2005-04-21	Verfahren zur behandlung navikularer krankheiten bei pferden
DK0569411T3 (da)	1995-08-28	Acylaminoalkylidenhydroxybiphosphonsyrer anvendelige til behandling af osteoartikulære sygdomme
DE59408645D1 (de)	1999-09-23	Lactulose-pastillen
SE9001592D0 (sv)	1990-05-04	A therapeutical composition
DE69626276D1 (de)	2003-03-27	Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
EA199800953A1 (ru)	1999-04-29	Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения

Legal Events

Date	Code	Title	Description
2007-12-14	FG	Patent granted	Ref document number: 118513 Country of ref document: FI

Date

Code

Title

Description

2007-12-14

Patent granted

Ref document number: 118513

Country of ref document: FI